Sort
16,300 grants matching “fatty liver disease”
Identification and Characterization of Loci Associated with Non-alcoholic Fatty Liver Disease
$578,049Nicholette D. Allred · Wake Forest University Health Sciences · R01 · FY2024 · DK
Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c
$577,831Michael S Brown · Ut Southwestern Medical Center · P01 · FY2012 · HL
The role of AEG-1 in NASH and NASH-HCC
$577,461Devanand Sarkar · Virginia Commonwealth University · R01 · FY2024 · DK
Unraveling the Complexity of Lipoprotein(a) Metabolism: Human Kinetic Studies
$577,363Gissette Reyes-Soffer · Columbia University Health Sciences · R01 · FY2020 · HL
Jagged-Notch signaling in NASH/fibrosis
$577,250Utpal Pajvani · Columbia University Health Sciences · R01 · FY2023 · DK
Functional Dissection of the 19p13.11 Haplotype
$577,199Marisa Wong Medina · Children'S Hospital & Res Ctr At Oakland · R56 · FY2016 · HL
Overcoming FVIII protein misfolding and cell toxicity
$576,990Randal J. Kaufman · Indiana University Indianapolis · P01 · FY2023 · HL
Biomarkers of Metabolic and Vascular Risk in Obesity
$576,629Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2010 · DK
Hepatic Steatosis Quantification with Ultrasound
$576,602Shigao Chen · Mayo Clinic Rochester · R01 · FY2022 · DK
QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload
$576,499Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
$576,471Ann Hsing · Stanford University · UG3 · FY2023 · HL
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
$576,336Daniel Thomas Claiborne · Wistar Institute · R01 · FY2024 · DK
The mTOR-ETV5 signaling in gastric X/A like cells and its role in hepatic lipid metabolism and steatosis
$576,286Randy J. Seeley · University Of Michigan At Ann Arbor · R01 · FY2024 · DK
Hepatic TrkB-T1 signaling in NASH pathogenesis and resolution
$576,164Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2024 · DK
Therapeutic Mitochondrial Uncouplers
$576,086Webster L Santos · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · DK
Prevention of Pediatric NAFLD in Hispanic Children
$576,074Miriam B. Vos · Emory University · R01 · FY2023 · NR
Collaborative Clinical Research on Non Alcoholic Stratohepatitis
$576,031Naga P. Chalasani · Indiana University Indianapolis · U01 · FY2010 · DK
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$575,954Carol A Casey · University Of Nebraska Medical Center · R01 · FY2017 · AA
The Saint Louis University Component of the NASH CRN
$575,680Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2021 · DK
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
$575,644Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · DK
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
$575,644Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · DK
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
$575,644Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · DK
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease
$575,584Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2023 · DK
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease
$575,584Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2025 · DK
Nuclear ATP citrate lyase and ischemia/reperfusion injury in steatotic liver
$575,339Weizhen Zhang · University Of Michigan At Ann Arbor · R01 · FY2024 · DK